Purinergic signals regulate daily S-phase cell activity in the ciliary marginal zone of the zebrafish retina

J Biol Rhythms. 2011 Apr;26(2):107-17. doi: 10.1177/0748730410395528.

Abstract

Regeneration and growth that occur in the adult teleost retina have been helpful in identifying molecular and cellular mechanisms underlying cell proliferation and differentiation. Here, it is reported that S-phase cell number, in the ciliary marginal zone (CMZ) of the adult zebrafish retina, exhibits day-night variations with a mid-light phase peak. Oscillations persist for 24 h in constant darkness (DD), suggesting control by a circadian component. However, variations in the S-phase nuclei number were rapidly dampened and not present during and after a second day in DD. An ADPβS treatment significantly enhanced S-phase activity at night to mid-light levels, as assessed by in vivo BrdU incorporation in a 2-h interval. Moreover, daylight increase in S-phase cell number was completely abolished when extracellular nucleotide levels or their extracellular hydrolysis by ectonucleoside triphosphate diphosphohydrolases (NTPDases) were significantly disrupted or when a selective antagonist of purinergic P2Y1 receptors was intraocularly injected before BrdU exposure. Extracellular nucleotides and NTPDase action were also important for maintaining nocturnal low levels of S-phase activity in the CMZ. Finally, we showed that mRNAs of NTPDases 1, 2 (3 isoforms), and 3 as well as of P2Y1 receptor are present in the neural retina of zebrafish. NTPDase mRNA expression exhibited a 2-fold increment in light versus dark conditions as assessed by quantitative RT-PCR, whereas P2Y1 receptor mRNA levels did not show significant day-night variations. This study demonstrates a key role for nucleotides, principally ADP as a paracrine signal, as well as for NTPDases, the plasma membrane-bound enzymes that control extracellular nucleotide concentration, for inducing S-phase cell entry in the CMZ-normally associated with retinal growth-throughout the light-dark cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate / analogs & derivatives
  • Adenosine Diphosphate / metabolism
  • Adenosine Diphosphate / pharmacology
  • Adenosine Triphosphate / metabolism
  • Animals
  • Apyrase / pharmacology
  • Cell Differentiation / drug effects
  • Cell Nucleus / metabolism
  • Circadian Clocks / physiology
  • Enzyme Inhibitors / pharmacology
  • Extracellular Space / metabolism
  • Hexokinase / pharmacology
  • Photoperiod
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • Pyrophosphatases / genetics
  • Pyrophosphatases / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, Purinergic P2Y1 / genetics
  • Receptors, Purinergic P2Y1 / metabolism*
  • Retina / cytology
  • Retina / enzymology
  • Retina / metabolism*
  • S Phase / drug effects
  • S Phase / physiology*
  • Signal Transduction
  • Thionucleotides / pharmacology
  • Zebrafish

Substances

  • Enzyme Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • RNA, Messenger
  • Receptors, Purinergic P2Y1
  • Thionucleotides
  • adenosine 5'-O-(2-thiodiphosphate)
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • Hexokinase
  • Pyrophosphatases
  • Apyrase